Nureca
: NURECA · Medical Equipment & Supplies
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Nureca's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Nureca Ltd is a digital-first consumer healthcare company specialising in home diagnostics, wellness devices, and personal fitness equipment. It operates primarily through well-known brands such as Dr Trust and Dr Physio.
Business Model
The company operates on a direct-to-consumer digital model, leveraging e-commerce channels to distribute its extensive portfolio of healthcare and wellness products.
- Active SKUs:277+
Management Commentary
Management continues to focus on product innovation and portfolio expansion to maintain its competitive edge in the home healthcare market.
- New Products Launched (Q1FY26):7
Growth Outlook
Growth is driven by the continuous introduction of new products and the expansion of the company's digital footprint in the wellness and diagnostics space.
Key Risks
- Intense Competition. The home healthcare and wellness market is highly fragmented with low barriers to entry, leading to significant pricing pressure from both established players and new entrants.
- Supply Chain Dependency. Reliance on third-party manufacturers and global supply chains for medical equipment components poses risks to inventory availability and margin stability.
- Regulatory Compliance. Changes in medical device regulations and quality standards in India could necessitate costly product modifications or impact the ability to sell certain SKUs.
- Digital Platform Dependence. As a digital-first company, Nureca is heavily reliant on third-party e-commerce platforms, making it vulnerable to changes in platform algorithms or commission structures.
Start your research today
Unlock AI insights, financials, peers and live data on Nureca and 5,000+ companies — free.
Key Metrics
REVENUE
₹181 Cr
TTM · consolidated
NET PROFIT
₹3 Cr
TTM · consolidated
EPS
₹2.71
TTM · consolidated
RETURN ON EQUITY
1.5%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
4.0%
TTM · consolidated
P/E
100.2x
Q4 FY26 · consolidated
EV/EBITDA
21.2x
Q4 FY26 · consolidated
EBITDA MARGIN
5.7%
TTM · consolidated
NET PROFIT MARGIN
-17.2%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.0%
Q4 FY26 · consolidated
Peers · Medical Equipment & Supplies
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
NurecaNURECA | ₹316 Cr | 122.16 | 30.60 | 65.2% | 5.7% | 1.5% | 4.0% | +37.9% |
Tarsons ProductsTARSONS | ₹1,768 Cr | 158.97 | 14.57 | 10.6% | 33.1% | 1.8% | 4.5% | +6.6% |
Laxmi DentalLAXMIDENTL | ₹1,098 Cr | 35.30 | 19.82 | — | 19.2% | 13.7% | 13.3% | -41.5% |
Vasa Denticity LimitedDENTALKART | ₹709 Cr | — | — | — | 4.0% | — | — | -34.1% |
Hemant Surgical Industries LimitedHSIL | ₹539 Cr | — | — | — | 10.0% | — | — | +27.0% |
Prevest DenproPREVEST | ₹464 Cr | — | — | — | 36.0% | — | — | -31.5% |
As of Q4 FY26
Financials
Nureca
: NURECA · Medical Equipment & Supplies
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Nureca's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Nureca Ltd is a digital-first consumer healthcare company specialising in home diagnostics, wellness devices, and personal fitness equipment. It operates primarily through well-known brands such as Dr Trust and Dr Physio.
Business Model
The company operates on a direct-to-consumer digital model, leveraging e-commerce channels to distribute its extensive portfolio of healthcare and wellness products.
- Active SKUs:277+
Management Commentary
Management continues to focus on product innovation and portfolio expansion to maintain its competitive edge in the home healthcare market.
- New Products Launched (Q1FY26):7
Growth Outlook
Growth is driven by the continuous introduction of new products and the expansion of the company's digital footprint in the wellness and diagnostics space.
Key Risks
- Intense Competition. The home healthcare and wellness market is highly fragmented with low barriers to entry, leading to significant pricing pressure from both established players and new entrants.
- Supply Chain Dependency. Reliance on third-party manufacturers and global supply chains for medical equipment components poses risks to inventory availability and margin stability.
- Regulatory Compliance. Changes in medical device regulations and quality standards in India could necessitate costly product modifications or impact the ability to sell certain SKUs.
- Digital Platform Dependence. As a digital-first company, Nureca is heavily reliant on third-party e-commerce platforms, making it vulnerable to changes in platform algorithms or commission structures.
Start your research today
Unlock AI insights, financials, peers and live data on Nureca and 5,000+ companies — free.
Key Metrics
REVENUE
₹181 Cr
TTM · consolidated
NET PROFIT
₹3 Cr
TTM · consolidated
EPS
₹2.71
TTM · consolidated
RETURN ON EQUITY
1.5%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
4.0%
TTM · consolidated
P/E
100.2x
Q4 FY26 · consolidated
EV/EBITDA
21.2x
Q4 FY26 · consolidated
EBITDA MARGIN
5.7%
TTM · consolidated
NET PROFIT MARGIN
-17.2%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.0%
Q4 FY26 · consolidated
Peers · Medical Equipment & Supplies
As of Q4 FY26